ABEO Highlights Potential Royalties as Ultragenyx Wins FDA Approval for FAYUVI, a Program Abeona Advanced as ABO-102
Market Chameleon (Fri, 18-Sep 10:08 AM)
ABEO highlights potential milestone and royalty upside after Ultragenyx wins FDA approval for FAYUVI
Market Chameleon (Fri, 18-Sep 8:11 AM)
Abeona Therapeutics Delivers 31% Sequential ZEVASKYN Revenue Growth in Q2, Expands Nationwide Treatment Network
Market Chameleon (Thu, 13-Aug 7:52 AM)
